Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
出版年份 2013 全文链接
标题
Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
作者
关键词
Metformin, Rosiglitazone, Liraglutide, Insulin Glargine, Exenatide
出版物
PHARMACOECONOMICS
Volume 32, Issue 1, Pages 15-27
出版商
Springer Nature
发表日期
2013-12-19
DOI
10.1007/s40273-013-0117-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
- (2011) S. Klarenbach et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
- (2011) William J. Valentine et al. CLINICAL THERAPEUTICS
- Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US
- (2011) W.C. Lee et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Cost-Effectiveness of Saxagliptin Versus NPH Insulin When Used in Combination with Other Oral Antidiabetes Agents in the Treatment of Type 2 Diabetes Mellitus in Poland
- (2011) Wladyslaw Grzeszczak et al. Diabetes Technology & Therapeutics
- Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
- (2011) M. J. Davies et al. DIABETIC MEDICINE
- Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: Yes
- (2011) André J. Scheen European Journal of Internal Medicine
- Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
- (2011) M. Brändle et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
- (2011) Ola Granström et al. Primary Care Diabetes
- Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK
- (2011) Amélie Beaudet et al. JOURNAL OF MEDICAL ECONOMICS
- Coste-efectividad de exenatida en comparación con insulina glargina en pacientes con obesidad y diabetes mellitus tipo 2 en España
- (2011) Gordon Goodall et al. Endocrinologia y Nutricion
- Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
- (2010) A. Sinha et al. DIABETES CARE
- A population model evaluating the costs and benefits associated with different oral treatment strategies in people with type 2 diabetes
- (2010) P. McEwan et al. DIABETES OBESITY & METABOLISM
- A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
- (2010) Jean-Eric Tarride et al. PHARMACOECONOMICS
- Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
- (2009) Maureen J. Lage et al. ADVANCES IN THERAPY
- Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
- (2009) T. Mittendorf et al. DIABETES OBESITY & METABOLISM
- Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
- (2008) Anette Woehl et al. Cardiovascular Diabetology
- Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy
- (2008) B. Schwarz et al. DIABETES OBESITY & METABOLISM
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started